Results observed in the murine melanoma model in vivo after treatment with D16F7 mAb indicated not only a strong reduction in the tumor mass but also an almost complete elimination of bone infiltrate that, in untreated controls, presented a high percentage of PlGF-positive melanoma cells. Here, PGF is linked to melanoma.